Immucor is a leading provider of transfusion and transplantation diagnostic products worldwide.
A US based company established in 1982.
Immucor’s transfusion diagnostics segment develops, manufactures and sells a complete line of serology-based reagents and instruments used by hospitals, reference labs and donor centers to perform pre-transfusion typing and screening of blood. Their products, which help ensure donor-recipient compatibility, deliver accurate, pre-transfusion test results in an efficient and productive way for our customers.
Immucor’s portfolio of pre-transfusion diagnostics systems includes scalable and flexible automation options to accommodate a variety of operational sizes, volumes and complexities.
Immucor has developed molecular typing assays using their multiplex, polymerase chain reaction (PCR) technology marketed as the BeadChip™ System.
Immucor’s transplant diagnostics segment develops, manufactures and sells a complete line of assays to perform pre-transplant typing, screening and post-transplant monitoring.
Immucor’s broad portfolio of molecular and antibody-based assays use ELISA and xMAP® technology to evaluate human leukocyte antigens (HLA) compatibility between donors and recipients and are sold to HLA labs worldwide.
Immucor has offices in United States - Georgia (Headquarter), Canada, Belgium, France, Germany, Italy, Spain, Portugal, United Kingdom, Japan & India.
